135 related articles for article (PubMed ID: 11403175)
1. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
[TBL] [Abstract][Full Text] [Related]
2. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H
Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948
[TBL] [Abstract][Full Text] [Related]
3. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H
J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728
[TBL] [Abstract][Full Text] [Related]
4. Effects of extracellular Na+ and Ca2+ ions and Ca2+ channel modulators on the cell-associated activity of 99mTc-MIBI and 99mTc-tetrofosmin in tumour cells.
Arbab AS; Ueki J; Koizumi K; Araki T
Nucl Med Commun; 2003 Feb; 24(2):155-66. PubMed ID: 12548040
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
[TBL] [Abstract][Full Text] [Related]
7. Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
Nucl Med Commun; 1997 Mar; 18(3):235-40. PubMed ID: 9106777
[TBL] [Abstract][Full Text] [Related]
8. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
9. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
10. Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Cordobes MD; Moretti JL; de Beco V; Benazzouz F; Starzec A
Nucl Med Commun; 1999 May; 20(5):433-7. PubMed ID: 10404528
[TBL] [Abstract][Full Text] [Related]
11. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
de Jong M; Bernard BF; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; Krenning EP
Eur J Nucl Med; 1996 Oct; 23(10):1361-6. PubMed ID: 8781141
[TBL] [Abstract][Full Text] [Related]
12. Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin.
Adalet I; Koçak M; Ogŭz H; Alagöl F; Cantez S
Nucl Med Commun; 1999 Apr; 20(4):353-9. PubMed ID: 10319355
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
14. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Al-Saeedi FJ; Bitar M; Pariyani S
J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
[TBL] [Abstract][Full Text] [Related]
15. Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.
Perek N; Denoyer D; Dubois F; Koumanov F
Gen Physiol Biophys; 2002 Dec; 21(4):381-404. PubMed ID: 12693711
[TBL] [Abstract][Full Text] [Related]
16. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
[TBL] [Abstract][Full Text] [Related]
17. Limitations of (99m)Tc tetrofosmin in assessing reversal effects of verapamil on the function of multi-drug resistance associated protein 1.
Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Nucl Med Commun; 2004 Jun; 25(6):585-9. PubMed ID: 15167518
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.
Ballinger JR; Bannerman J; Boxen I; Firby P; Hartman NG; Moore MJ
J Nucl Med; 1996 Sep; 37(9):1578-82. PubMed ID: 8790223
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
20. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
